PDF herunterladen
Open Access
CC BY 4.0 · Indian J Med Paediatr Oncol 2024; 45(02): 153-156
DOI: 10.1055/s-0043-1777354
Original Article

Clinical Profile of Male Patients Presenting with Breast Cancer in Kashmir Valley

Authors

  • Ulfat Ara Wani

    1   Department of Medical Oncology, Sher-i-Kashmir institute of Medical Sciences, Soura Srinagar, Jammu and Kashmir, India

  • Umeek Jeelani

    2   Department of ENT, Government Medical College Srinagar, Srinagar, Jammu and Kashmir, India

  • Basharat Ara Wani

    2   Department of ENT, Government Medical College Srinagar, Srinagar, Jammu and Kashmir, India

  • Shahida Nasreen

    3   Department of Radiation Oncology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India
Weitere Informationen
Auch verfügbar auf
  Lizenzen und Reprints
Preview

Abstract

Introduction Breast cancer is a rare disease in males with unknown etiology and variable rate of incidence among different ethnic and geographical groups.

Objectives This article studies the clinical profile of male breast cancer in Kashmir Valley of India

Materials and Methods This study was a retrospective study conducted at a superspecialty hospital (Government Medical College Srinagar) in the department of medical oncology over a period of 4 years from January 2017 to October 2021. All male patients who presented with a histopathology-proven diagnosis of breast cancer were included and studied.

Results A total of 8 male patients with breast cancer were studied. The median age at diagnosis was 55 years. Most of the patients were from rural background. The most common presenting symptom was breast lump followed by ulceration. The most common location of the tumor was retroareolar. Infiltrating ductal carcinoma (100%) was the only subtype present in our patients. Locally advanced disease accounted for most of the cases. Among stage IV patients two had bone as the metastatic site and one patient had in addition lung metastasis. Immunohistochemistry analysis revealed that all patients (100%) were hormone receptor positive with only one patient being triple positive (12.5%). None of the patients had triple negative disease in our study. In our study 6 patients were treated with multimodalities (surgery, chemo, radiation, and targeted agents).

Conclusion Male breast cancer is a well-recognized entity and the gender gap of disease need to be abolished. Awareness among masses and training of general practitioners is needed to pick cases at early stage.

Keywords

male breast cancer - triple negative - ductal carcinoma - lung metastasis

Patient Consent

None declared




Publikationsverlauf

Artikel online veröffentlicht:
21. März 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India